$NRIX insiders have traded $NRIX stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales. We have seen ...
21h
Zacks Investment Research on MSNZymeworks (ZYME) Soars 5.4%: Is Further Upside Left in the Stock?Zymeworks Inc. (ZYME) shares soared 5.4% in the last trading session to close at $11.70. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares ...
The fireside chat will be webcast live and may be accessed via a link in the Investors section of the Nurix website. The archived webcast will be available for 30 days after the event. About Nurix ...
SAN FRANCISCO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) is expected to announce its earnings results on Thursday, February 20th. Analysts expect the company to announce earnings of ($0.67 ...
In trading on Friday, shares of Nurix Therapeutics Inc (Symbol: NRIX) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $14.50 per share. By ...
J.P. Morgan analyst Eric Joseph maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report) today and set a price target of $30.00. The company’s shares closed yesterday at $19.56.
SAN FRANCISCO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
On April 5, 2023, Stefani A. Wolff notified Nurix Therapeutics (NRIX) of her decision to resign from her position as Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results